Form 4: ClearPoint Neuro Director R. John Fletcher Settles Restricted Stock Units
SEC Form 4 Filing
Director R. John Fletcher settles 21,093 restricted stock units into common stock of ClearPoint Neuro, Inc.
Summary
- On May 16, 2025, R. John Fletcher, a director of ClearPoint Neuro, Inc., settled 21,093 restricted stock units (RSUs) into shares of common stock.
- The RSUs vested on the earlier of the first anniversary of the grant date or the day immediately preceding the company's 2025 annual meeting of stockholders.
- Following the transaction, Fletcher directly owns 115,491 shares of ClearPoint Neuro common stock.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock unit vesting, so it has a neutral sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The settlement of RSUs may have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/16/2024 | Reporting person was granted 21,093 restricted stock units. |
| 05/16/2025 | Restricted stock units settled for common stock. |
| 05/19/2025 | Date of signature for the Form 4 filing. |
Keywords
ClearPoint Neuro, CLPT, R. John Fletcher, restricted stock units, RSU, Form 4, beneficial ownership, director, common stock, settlement, vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.